{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:54Z","timestamp":1786118814405,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/iae.0b013e31802ea591","type":"journal-article","created":{"date-parts":[[2007,7,2]],"date-time":"2007-07-02T04:04:57Z","timestamp":1183349097000},"page":"770-777","source":"Crossref","is-referenced-by-count":6,"title":["OCULAR TISSUE DISTRIBUTION OF BETAMETHASONE AFTER ANTERIOR-EPISCLERAL, POSTERIOR-EPISCLERAL, AND ANTERIOR-INTRASCLERAL PLACEMENT OF NONBIODEGRADABLE IMPLANTS"],"prefix":"10.1097","volume":"27","author":[{"given":"KOMEI","family":"OKABE","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HIDEYA","family":"KIMURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUNKO","family":"OKABE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YUICHIRO","family":"OGURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210130","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery.","volume":"26","author":"Ahmed","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-17-20210130","first-page":"1181","article-title":"Diffusion of high molecular weight compounds through sclera.","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-17-20210130","first-page":"1186","article-title":"Transscleral delivery of bioactive protein to the choroid and retina.","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R4-17-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease.","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv Drug Deliver Rev"},{"key":"R5-17-20210130","first-page":"1893","article-title":"Human scleral permeability. Effects of age, cryotherapy, transscleral diode laser, and surgical thinning.","volume":"36","author":"Olsen","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-17-20210130","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9394(99)80096-8","article-title":"Human sclera: thickness and surface area.","volume":"125","author":"Olsen","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"R7-17-20210130","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1167\/iovs.02-0375","article-title":"Biodegradable intrascleral delivery system of steroid to the posterior segment of the eye.","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R8-17-20210130","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.02-0956","article-title":"Intraocular tissue distribution of betamethasone following intrascleral administration using a non-biodegradable sustained drug delivery device.","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-17-20210130","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/1097-4636(20000915)51:4<635::AID-JBM11>3.0.CO;2-O","article-title":"Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.","volume":"51","author":"Kunou","year":"2000","journal-title":"J Biomed Mater Res"},{"key":"R10-17-20210130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00055735-199406000-00005","article-title":"Intravitreal drug administration with depot devices.","volume":"5","author":"Metrikin","year":"1994","journal-title":"Curr Opin Ophthalmol"},{"key":"R11-17-20210130","doi-asserted-by":"crossref","first-page":"2714","DOI":"10.1248\/cpb.29.2714","article-title":"Controlled release of prednisolone from ethylene-vinyl acetate copolymer matrix.","volume":"29","author":"Miyazaki","year":"1981","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"R12-17-20210130","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1248\/bpb.24.78","article-title":"A protective effect against undesirable increase of dihydroetorphine permeation through damaged skin by using pressure-sensitive adhesive tape with an ethylene-vinyl acetate co-polymer membrane.","volume":"24","author":"Ohmori","year":"2001","journal-title":"Biol Pharm Bull"},{"key":"R13-17-20210130","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0939-6411(02)00088-7","article-title":"Enhanced transdermal delivery of triprolidine from the ethylene-vinyl acetate matrix.","volume":"54","author":"Shin","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"key":"R14-17-20210130","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0939-6411(02)00051-6","article-title":"Controlled release of triprolidine using ethylene-vinyl acetate membrane and matrix systems.","volume":"54","author":"Shin","year":"2002","journal-title":"Eur J Pharm Biopharm"},{"key":"R15-17-20210130","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10731198909118280","article-title":"Tumoricidal effect of controlled-release polymeric needle devices containing Adriamycin HCl in tumor-bearing mice.","volume":"17","author":"Lin","year":"1989","journal-title":"Biomater Artif Cells Artif Organs"},{"key":"R16-17-20210130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0165-0270(97)00193-3","article-title":"Small drug sample fabrication of controlled release polymers using the microextrusion method.","volume":"80","author":"Haik-Creguer","year":"1998","journal-title":"J Neurosci Methods"},{"key":"R17-17-20210130","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1167\/iovs.04-0091","article-title":"Controlled drug release from an ocular implant: an evaluation using dynamic three-dimensional magnetic resonance imaging.","volume":"45","author":"Kim","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-17-20210130","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2005.08.007","article-title":"A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.","volume":"82","author":"Robinson","year":"2006","journal-title":"Exp Eye Res"},{"key":"R19-17-20210130","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006982-200009000-00003","article-title":"Macular buckling for retinal detachment due to macular hole in highly myopic eyes with posterior staphyloma.","volume":"20","author":"Sasoh","year":"2000","journal-title":"Retina"},{"key":"R20-17-20210130","first-page":"29","article-title":"Use of a special macular explant in surgery for retinal detachment with macular hole.","volume":"24","author":"Ando","year":"1980","journal-title":"Jpn J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IAE.0b013e31802ea591","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:39:25Z","timestamp":1786034365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006982-200707000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0b013e31802ea591","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}